A Beginner's Guide to Alternative Splicing Analysis: Key Concepts, Tools, and Workflows for RNA-seq

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• Alternative splicing analysis quantifies relative transcript isoform usage, distinguishing it from standard gene-level differential expression by preserving isoform-specific information. This is critical because different isoforms can encode proteins with distinct functions, localizations, or stability properties, impacting biological processes and disease states.
• Major alternative splicing event types include exon skipping, intron retention, alternative 5' and 3' splice site selection, and mutually exclusive exons, each with unique biological implications such as introducing premature termination codons or regulating stress responses in plants.
• Percent Spliced In (PSI) is a common quantification metric representing the proportion of transcripts including a specific feature, but it is a relative measure that requires careful interpretation alongside absolute expression levels to assess biological significance.
• Event-level analysis, focusing on specific splicing patterns like cassette exons, is generally more robust with short-read RNA-seq data due to its reliance on reads spanning splice junctions. Isoform-level analysis, which reconstructs full-length transcripts, is more ambitious and benefits from long-read sequencing technologies for improved isoform discovery.
• Essential workflow steps include rigorous quality control of raw sequencing reads, splicing-aware read alignment using tools like STAR or HISAT2, quantification of splicing events or isoforms, and differential splicing analysis, followed by critical visualization (e.g., Sashimi plots) and validation, potentially with RT-PCR.
• Practical implementation necessitates defining the biological question, inventorying data and resources (including stranded library preparation and biological replicates), choosing an analysis path (event-level vs. isoform-level), and maintaining detailed records of sample metadata, tool versions, and parameters for reproducibility.

Alternative splicing analysis is the computational process of identifying and quantifying transcript isoform usage from RNA sequencing data to reveal regulatory changes that standard gene-level differential expression analysis misses. This guide provides biology students, researchers, laboratory professionals, and life-science practitioners with a practical entry point into splicing analysis, covering the core concepts, tool choices, workflow decisions, quality controls, and interpretation limits that define this field.

What Alternative Splicing Analysis Measures and Why It Matters

Alternative splicing is an essential component of gene expression regulation that contributes to the diversity of proteomes. Recent developments in RNA sequencing technologies, combined with the advent of computational tools, have enabled transcriptome-wide studies of alternative splicing at an unprecedented scale and resolution [<a href="#ref-1">1</a>]. When you perform a standard RNA-seq differential expression analysis, you typically measure total gene expression by summing reads across all exons of a gene. Splicing analysis asks a different question: are the relative proportions of transcript isoforms changing between conditions, even when total gene expression remains constant?

RNA mis-splicing can cause human disease, and targeting alternative splicing has led to the development of novel therapeutics. Splice variants diversify the repertoire of biomarkers and functionally contribute to drug resistance [<a href="#ref-1">1</a>]. In plant systems, alternative splicing regulates responses to abiotic stresses such as salt stress, where exon skipping was the most prevalent event type in tomato roots under saline conditions [<a href="#ref-2">2</a>]. In soybean, intron retention was the most frequent alternative splicing event type in response to bicarbonate stress [<a href="#ref-3">3</a>]. These examples illustrate that splicing changes are biologically meaningful across kingdoms and experimental contexts.

For a newcomer, the practical distinction is straightforward. Gene-level analysis collapses all isoforms into one measurement. Splicing analysis preserves isoform-level information and asks whether the splicing machinery is producing different transcript structures under different conditions. This matters because different isoforms of the same gene can encode proteins with different functions, localizations, or stability properties.

Core Concepts in Splicing Biology and Quantification

The Major Splicing Event Types

Alternative splicing events are typically classified into several recurring patterns. Exon skipping occurs when an internal exon is excluded from the mature mRNA. Intron retention occurs when an intron is not removed from the transcript. Alternative 5' splice site selection uses a different donor site at the beginning of an intron. Alternative 3' splice site selection uses a different acceptor site at the end of an intron. Mutually exclusive exons occur when exactly one of two adjacent exons is included.

These event types have different biological implications. Intron retention can introduce premature termination codons that affect transcript stability or coding potential [<a href="#ref-4">4</a>]. In a study of environmental pollutant PCB 153 exposure in a neuronal model, retained intron events were predicted to introduce premature termination codons, suggesting potential effects on transcript stability or coding potential [<a href="#ref-4">4</a>]. Exon skipping was the most prevalent event type in salt-stressed tomato roots [<a href="#ref-2">2</a>], while intron retention dominated in bicarbonate-stressed soybean [<a href="#ref-3">3</a>]. The dominant event type can vary by species, tissue, and stress condition.

Percent Spliced In and Other Quantification Metrics

The most common quantification metric in splicing analysis is Percent Spliced In, often abbreviated as PSI or Ψ. For a cassette exon, PSI represents the percentage of transcripts that include the exon. A PSI value of 0.8 means 80 percent of transcripts include the exon and 20 percent exclude it. Differential splicing analysis compares PSI values between conditions and identifies events where the inclusion ratio changes significantly.

PSI is a relative measure. It does not tell you the absolute abundance of a transcript, only the proportion of isoforms that include a particular feature. This distinction matters for interpretation. A gene with low overall expression can have a large PSI change that involves very few actual transcript molecules. Conversely, a highly expressed gene can have a small PSI change that involves many transcript molecules. Both types of changes can be biologically relevant, but they require different interpretive frameworks.

Isoform-Level versus Event-Level Analysis

Two complementary analysis strategies exist. Event-level analysis focuses on specific splicing patterns such as cassette exons or retained introns and quantifies the inclusion ratio for each event. Isoform-level analysis attempts to reconstruct and quantify full-length transcript isoforms, then compares isoform abundances between conditions.

Event-level analysis is generally more robust with short-read RNA-seq data because it focuses on local splicing patterns that are directly supported by reads spanning splice junctions. Isoform-level analysis is more ambitious because it must assign reads to specific combinations of exons across potentially long distances. Long-read sequencing technologies such as PacBio Iso-seq can identify more novel genes and transcripts, as well as more alternative splicing events, compared to short-read RNA-seq [<a href="#ref-3">3</a>]. However, short-read RNA-seq remains the most common data type due to cost and availability.

At a Glance: Alternative Splicing Analysis Decision Table

RNA-seq Data Inputs and Experimental Design for Splicing Analysis

Sequencing Depth and Read Length Requirements

Splicing analysis places different demands on sequencing data than gene-level expression analysis. Detection of splice junctions requires reads that span exon-exon boundaries. Longer reads can span more distant junctions and provide more confident alignment. Paired-end sequencing is strongly preferred over single-end because the two reads from a fragment can be used to confirm that a junction is real and to improve alignment across repetitive regions.

Sequencing depth requirements depend on the goals of the analysis. Detecting highly expressed splicing events requires less depth than detecting rare isoforms or subtle PSI changes. For differential splicing analysis, biological replication matters more than extreme depth. A study with four biological replicates per condition at moderate depth will generally provide more reliable differential splicing calls than a study with two replicates at very high depth.

Stranded Library Preparation

Stranded RNA-seq libraries preserve the information about which DNA strand produced the RNA transcript. This information is valuable for splicing analysis because it disambiguates reads that map to overlapping genes on opposite strands. Many modern library preparation protocols produce stranded data, and most splicing analysis tools can use this information to improve accuracy.

If you are working with publicly available data, check whether the libraries were stranded before choosing analysis tools and parameters. Some tools assume stranded data by default, and using unstranded data with these settings can produce incorrect results.

Biological Replicates and Batch Structure

Differential splicing analysis requires biological replicates to estimate within-condition variability. The number of replicates needed depends on the biological variability of the system and the magnitude of splicing changes you expect to detect. A common starting point is three to four biological replicates per condition, with more replicates providing greater statistical power for detecting subtle changes.

Batch effects are a major concern in splicing analysis. If all control samples are processed in one batch and all treated samples in another, technical differences between batches can be misinterpreted as biological splicing changes. Record batch information and include it in the statistical model when possible. The Galaxy Training Network provides accessible workflow training that covers experimental design considerations and reproducibility context for RNA-seq analysis [<a href="#ref-6">6</a>].

Building a Splicing Analysis Workflow

Step 1: Quality Control of Raw Sequencing Reads

Before any splicing analysis, assess the quality of the raw sequencing data. Check per-base quality scores, GC content, adapter contamination, and duplication rates. Poor quality bases at read ends can cause spurious alignments that create false splicing calls. Adapter contamination can prevent reads from aligning entirely or cause them to align incorrectly.

The Carpentries Lessons provide foundational computing and data skills that are useful for managing and processing sequencing data [<a href="#ref-7">7</a>]. These lessons cover shell, Git, and programming training that supports reproducible analysis workflows. For laboratory professionals who are new to command-line analysis, investing time in these foundational skills reduces errors in later analysis steps.

Step 2: Read Alignment to the Reference Genome

Splicing-aware aligners are required for RNA-seq data because they can align reads across exon-exon junctions. These aligners use the reference genome sequence and known splice junction information to place reads that span introns. The choice of aligner affects downstream analysis because different aligners have different strengths in handling multi-mapping reads, novel junctions, and alignment quality.

The reference genome and annotation files should come from authoritative sources. NCBI Data Resources provide official descriptions of databases, search systems, sequence resources, and analysis services that support genome-based analysis [<a href="#ref-8">8</a>]. Using consistent genome builds and annotation versions across all samples in a study is essential for comparability.

Step 3: Quantification of Splicing Events or Isoforms

After alignment, the next step is to quantify splicing. Event-level tools count reads that support inclusion versus exclusion of specific splicing features. Isoform-level tools estimate the abundance of full-length transcripts using the alignment information and the transcript annotation.

The Bioconductor Project provides official package, workflow, installation, and reproducible genomic-analysis documentation for many splicing analysis tools [<a href="#ref-9">9</a>]. Browsing the Bioconductor package repository can help you identify maintained tools with active user communities and documentation.

Step 4: Differential Splicing Analysis

Differential splicing analysis compares splicing ratios between conditions and identifies statistically significant changes. The statistical models used by different tools vary in how they account for biological variability, read depth, and event complexity. Some tools model the inclusion and exclusion read counts directly, while others first estimate PSI values and then test for differences.

The output of differential splicing analysis is typically a table of splicing events with test statistics, p-values, and adjusted p-values for multiple testing correction. Filtering by effect size as well as statistical significance is recommended because very small PSI changes can achieve statistical significance with deep sequencing but may not be biologically meaningful.

Step 5: Visualization and Validation

Visual inspection of splicing events is a critical quality control step. Sashimi plots show the read coverage across exons and the junction reads that support specific splicing patterns. Genome browser views allow you to examine the alignment of reads to the reference genome and annotation. A protocol for visual analysis of alternative splicing in RNA-seq data using integrated genome browser provides a structured approach to this validation step [<a href="#ref-5">5</a>].

For key findings, consider validating with an independent method such as RT-PCR across the affected splice junction. This is especially important when the splicing change will be followed up with functional experiments.

Tools and Resources for Splicing Analysis

Alignment Tools

STAR and HISAT2 are widely used splicing-aware aligners that can handle the large data volumes produced by modern RNA-seq experiments. Both tools can discover novel splice junctions and provide the alignment files needed for downstream splicing analysis. The choice between them often comes down to computational resources and personal preference, as both produce alignments that work with common downstream tools.

Event-Level Quantification and Differential Splicing Tools

rMATS is a popular tool for detecting differential alternative splicing events using a hierarchical model that accounts for biological variability between replicates. It reports PSI values and statistical significance for each event type. MISO uses a Bayesian approach to estimate PSI values and compare them between conditions. SUPPA2 computes PSI values from transcript quantification and performs differential splicing analysis. LeafCutter focuses on intron excision patterns and can detect splicing changes that involve novel junctions.

Each tool has strengths and limitations. rMATS requires a reference annotation and detects annotated event types. LeafCutter does not require an annotation and can find novel splicing changes. SUPPA2 is fast because it works from transcript quantification instead of raw alignments. For critical findings, running two tools with different approaches and checking for concordance is a reasonable validation strategy.

Isoform-Level Tools

Cufflinks and StringTie can assemble transcripts and quantify isoform abundances from short-read data. Salmon and kallisto use lightweight alignment or pseudo-alignment approaches that are very fast and can quantify transcript-level abundances directly from raw reads. These tools require a transcript annotation and produce estimates of transcript abundance that can be used for isoform-level differential analysis.

The nf-core Documentation provides community pipeline standards, usage, configuration, and reproducible workflow context that can help you assemble a complete splicing analysis pipeline [<a href="#ref-10">10</a>]. Using a community-maintained pipeline can reduce the burden of installing and configuring individual tools.

Long-Read Analysis Tools

Long-read sequencing produces reads that can span entire transcripts, simplifying isoform detection. Tools such as FLAIR and IsoQuant can process long-read data to identify isoforms and quantify their abundance. However, long-read data has higher error rates than short-read data, and analysis tools must account for this. A hybrid approach that combines long-read isoform discovery with short-read quantification can leverage the strengths of both technologies [<a href="#ref-3">3</a>].

Practical Implementation Steps for Your First Splicing Analysis

Step 1: Define the Biological Question and Analysis Scope

Write down the specific question you want to answer. Are you looking for any splicing changes between two conditions, or are you focused on a specific set of genes? Do you expect large changes in a few genes or small changes in many genes? The answers to these questions determine the analysis strategy and the statistical power required.

Step 2: Inventory Your Data and Resources

List all the samples you have, including the condition labels, batch information, sequencing platform, read length, and whether the library preparation was stranded. Check that all samples have sufficient sequencing depth for splicing analysis. Confirm that you have access to the reference genome and annotation files for your organism of interest.

Step 3: Choose Your Analysis Path

Decide whether to use a single integrated pipeline or to assemble tools manually. The Galaxy Training Network provides accessible workflow training and analysis tutorials that can guide you through a complete RNA-seq analysis including splicing [<a href="#ref-6">6</a>]. The nf-core community provides production-ready pipelines that follow community standards [<a href="#ref-10">10</a>]. For a first analysis, using a tested pipeline reduces the chance of configuration errors.

Step 4: Run Quality Control and Alignment

Run quality control on all samples before alignment. Document the quality metrics and note any samples that fail quality thresholds. Align all samples to the same reference genome build using consistent parameters. Record the alignment statistics, including the percentage of reads that align and the percentage that align to splice junctions.

Step 5: Quantify Splicing Events and Run Differential Analysis

Run your chosen quantification and differential splicing tools. Save the complete output tables, beyond the significant events. Record the tool versions and parameters used, because these details affect reproducibility.

Step 6: Visualize and Interpret Results

Select the top differential splicing events and visualize them to confirm that the automated calls are supported by the read data. Examine the biological context of the affected genes. Consider whether the splicing changes are consistent with the known biology of your system.

Step 7: Document and Report

Record all analysis steps, tool versions, parameters, and quality metrics in a lab notebook or electronic documentation system. This documentation is essential for reproducing the analysis and for reporting results in publications.

Records and Measurements for Splicing Analysis

Essential Records to Maintain

Maintain a sample metadata table that includes sample identifiers, condition labels, batch information, sequencing depth, read length, strandedness, and any quality control metrics. Record the reference genome build and annotation version used for alignment and quantification. Document all tool versions and parameters in a configuration file or analysis log.

The EMBL-EBI Training provides bioinformatics learning pathways, data-resource training, and practical analysis education that can help you understand what records are expected in professional bioinformatics practice [<a href="#ref-11">11</a>]. Following established documentation standards from the start makes later publication and data sharing easier.

Key Measurements to Track

Track the number of reads per sample, the alignment rate, the number of reads mapping to splice junctions, and the number of splicing events detected per sample. Monitor the distribution of PSI values across events to identify any samples that look unusual. For differential analysis, track the number of significant events at different significance thresholds and effect size cutoffs.

Quality Metrics for Splicing Analysis

The quality of splicing analysis depends on the quality of the alignments. Check the percentage of reads that align uniquely, the percentage that align to multiple locations, and the percentage that align to known versus novel junctions. High rates of multi-mapping reads can indicate repetitive regions or poor reference quality. High rates of novel junctions can indicate genuine novel splicing or alignment errors.

Common Failure Patterns and How to Avoid Them

Failure Pattern 1: Insufficient Sequencing Depth for Splicing Events

Splicing analysis requires reads that span exon-exon junctions. If sequencing depth is too low, many junctions will have too few reads to estimate PSI reliably. This is especially problematic for lowly expressed genes. The solution is to sequence more deeply or to restrict the analysis to genes with sufficient read coverage.

Failure Pattern 2: Ignoring Batch Effects

If samples from different conditions are processed in different batches, technical variation can create false splicing differences. This is a common cause of irreproducible results. The solution is to randomize samples across batches, include batch information in the statistical model, and check for batch-related patterns in the data.

Failure Pattern 3: Overinterpreting Small PSI Changes

A statistically significant PSI change of 0.05 may be real but biologically unimportant. Conversely, a large PSI change in a lowly expressed gene may involve very few transcript molecules. The solution is to report both statistical significance and effect size, and to consider the absolute expression level of the affected gene.

Failure Pattern 4: Relying on a Single Tool Without Validation

Different splicing analysis tools can produce different results for the same data. This is because they use different statistical models, different event definitions, and different alignment requirements. The solution is to validate critical findings with a second tool or with an independent experimental method.

Failure Pattern 5: Using Inconsistent Genome Annotations

If samples are aligned to different genome builds or annotation versions, the splicing events detected will not be comparable. The solution is to use the same reference genome and annotation for all samples in a study and to document the versions used.

Failure Pattern 6: Neglecting Visualization

Automated splicing event calls can be wrong. Reads can align incorrectly, annotations can be incomplete, and statistical models can make errors. The solution is to visually inspect the top events before reporting them as findings.

Limitations and Interpretation Boundaries

Short-Read Limitations

Short-read RNA-seq cannot always determine the full structure of a transcript. Reads are typically 50 to 150 base pairs long, while transcripts can be thousands of base pairs long. This means that isoform-level quantification from short-read data involves statistical inference instead of direct observation. Long-read sequencing can resolve full transcript structures but has lower throughput and higher error rates [<a href="#ref-3">3</a>].

Annotation Dependence

Most splicing analysis tools depend on a reference annotation. If the annotation is incomplete or incorrect, the analysis will miss novel splicing events or misclassify known ones. Annotation-free approaches can discover novel events but require more computational resources and produce results that are harder to interpret.

Statistical Power

Detecting differential splicing requires sufficient biological replication and sequencing depth. Studies with few replicates or shallow sequencing will only detect large splicing changes. The absence of significant splicing changes does not prove that splicing is unchanged, only that the study had insufficient power to detect changes.

Tissue and Cell Type Specificity

Splicing patterns are often tissue-specific and cell type-specific. A splicing change detected in a mixed tissue sample may reflect changes in cell type composition instead of changes in splicing within a single cell type. This is a particular concern for studies of complex tissues.

Correlation versus Causation

Splicing analysis identifies associations between conditions and splicing changes. It does not establish that the splicing change causes the observed phenotype. Functional validation experiments are required to establish causality.

Safety and Regulatory Context for Splicing Analysis

Data Management and Privacy

RNA-seq data from human samples contains sensitive biological information. Researchers must follow institutional review board requirements and data protection regulations when storing, analyzing, and sharing human sequencing data. Public databases such as NCBI provide controlled access mechanisms for sensitive data [<a href="#ref-8">8</a>].

Reproducibility Standards

Scientific journals increasingly require that RNA-seq analyses be reproducible. This means providing access to the analysis code, tool versions, and parameters used in the study. The nf-core community standards emphasize reproducible workflow practices [<a href="#ref-10">10</a>], and the Galaxy Training Network provides tutorials that teach reproducible analysis approaches [<a href="#ref-6">6</a>].

Publication Requirements

When publishing splicing analysis results, report the alignment tool and version, the quantification tool and version, the statistical methods, the genome build and annotation version, and the quality control metrics. This information allows other researchers to evaluate and reproduce the analysis.

Professional Escalation Criteria

When to Seek Expert Help

If you encounter any of the following situations, consider consulting a bioinformatics specialist or a colleague with more experience in splicing analysis. First, if your alignment rates are unexpectedly low or highly variable across samples. Second, if different analysis tools produce conflicting results for the same data. Third, if you are working with a non-model organism that lacks a high-quality reference genome. Fourth, if you need to analyze data from long-read sequencing platforms for the first time. Fifth, if your results will guide clinical decisions or therapeutic development.

When to Question Your Results

Question your results if the splicing changes you detect are not supported by visual inspection of the read data. Question results that are driven by a single sample or a single batch. Question results that contradict well-established biology without a clear explanation. Question results that depend on a single tool or a single set of parameters.

When to Consider Additional Experiments

Consider additional experiments if you need to confirm that a splicing change is biologically functional. RT-PCR across the affected junction can confirm the splicing change. Western blotting can confirm changes at the protein level if isoform-specific antibodies are available. Functional assays can test whether the splicing change affects cellular behavior.

A Practical Decision Framework for Choosing Between Event-Level and Isoform-Level Splicing Analysis

Newcomers to splicing analysis often struggle with a fundamental workflow decision that the existing article has not yet addressed in practical terms: whether to pursue event-level analysis, isoform-level analysis, or a hybrid approach. This decision shapes every downstream choice, from tool selection to interpretation boundaries, and getting it wrong can waste weeks of computational time and produce results that do not answer the biological question. This section provides a concrete decision framework based on experimental goals, data characteristics, and available resources.

The Core Distinction That Drives Tool Choice

Event-level analysis asks a focused question: does the inclusion ratio of a specific splicing feature, such as a cassette exon or retained intron, change between conditions? This approach quantifies Percent Spliced In for individual events and tests whether these ratios differ significantly. Event-level tools count reads that support inclusion versus exclusion of specific features, making them directly interpretable and computationally efficient.

Isoform-level analysis asks a broader question: what are the full-length transcript structures present in each sample, and how do their abundances change between conditions? This approach attempts to reconstruct complete isoforms and quantify their relative expression. Isoform-level analysis provides more biological detail because it captures combinations of splicing events that occur together on the same transcript, but it carries higher uncertainty with short-read data because reads cannot span entire transcripts.

The decision between these approaches should not be made by convenience or habit. It should follow from the biological question, the quality of the reference annotation, the sequencing technology used, and the tolerance for false positives in the downstream validation pipeline.

Decision Criteria Based on Biological Questions

Start by writing the specific question you need to answer. If the question is whether a particular exon is included or excluded under different conditions, event-level analysis is the direct and sufficient approach. If the question is whether a gene produces a dominant full-length isoform that shifts under treatment, isoform-level analysis is required.

Consider the mechanism you expect to find. Splicing factors often regulate specific event types. For example, a study of HNRNPD in Wilms tumor identified a specific alternative splicing event in the apoptosis-related kinase MAP4K4, where the splicing factor perturbation directly altered the splicing pattern [<a href="#ref-12">12</a>]. This type of focused finding is well served by event-level analysis because the biological hypothesis centers on a specific regulatory relationship.

Conversely, if you are exploring a system with no prior splicing hypotheses, such as characterizing the transcriptomic response to a novel environmental exposure, isoform-level analysis may reveal coordinated changes across multiple splicing events that event-level analysis would present as disconnected findings. A study of PCB 153 exposure in a neuronal model identified 90 candidate differentially alternative splicing events and examined retained intron events for premature termination codons, an analysis that required understanding the full transcript context of each event [<a href="#ref-4">4</a>].

Decision Criteria Based on Data Characteristics

The sequencing technology available to you is a primary constraint. Short-read Illumina data supports event-level analysis most reliably because local splicing patterns are directly supported by reads spanning splice junctions. Isoform-level analysis from short reads involves statistical inference about which combinations of exons belong together, and this inference becomes less reliable as transcript length increases and as genes produce many isoforms.

Long-read sequencing changes this calculation. PacBio Iso-seq and similar technologies produce reads that can span entire transcripts, making isoform structures directly observable instead of inferred. A study combining Iso-seq and RNA-seq in soybean found that Iso-seq identified more novel genes and transcripts, as well as more alternative splicing events, compared to RNA-seq alone [<a href="#ref-3">3</a>]. If you have access to long-read data, isoform-level analysis becomes more tractable and more accurate.

The quality of the reference annotation is another critical factor. Event-level tools such as rMATS require a reference annotation that defines the expected splicing events. If the annotation is incomplete, the analysis will miss novel events. Isoform-level tools that work from transcript quantification also depend on annotation quality, though some can assemble transcripts de novo. For non-model organisms with incomplete annotations, annotation-free approaches such as LeafCutter may be more appropriate, but they produce results that are harder to interpret and validate.

Decision Criteria Based on Replication and Statistical Power

Biological replication is essential for both approaches, but the requirements differ. Event-level analysis tests many individual events, each with its own inclusion and exclusion read counts. The statistical power for each event depends on the read depth at that specific locus. Isoform-level analysis must estimate the abundance of each full-length isoform, which spreads the available reads across more categories and reduces power for any single isoform.

A practical rule is to use event-level analysis when you have three to four biological replicates per condition and moderate sequencing depth of 30 to 50 million paired-end reads per sample. Isoform-level analysis benefits from deeper sequencing and more replicates because the additional complexity of isoform assignment consumes statistical power. If you have fewer than three replicates per condition, event-level analysis of highly expressed genes is the more defensible choice.

A Scoring System for the Decision

To make the decision systematic instead of subjective, score your situation on five criteria. For each criterion, assign a value of 1 or 2 based on your circumstances.

First, biological question specificity. Score 1 if you are testing a specific hypothesis about particular exons or genes. Score 2 if you are exploring the global splicing landscape without prior hypotheses.

Second, annotation quality. Score 1 if you have a well-curated reference annotation for your organism. Score 2 if the annotation is incomplete, contains many predicted genes without transcript support, or is absent entirely.

Third, sequencing technology. Score 1 if you have short-read data only. Score 2 if you have long-read data or a hybrid dataset combining both technologies.

Fourth, replication depth. Score 1 if you have four or more biological replicates per condition. Score 2 if you have three or fewer.

Fifth, validation capacity. Score 1 if you can perform RT-PCR or other experimental validation for a limited number of top events. Score 2 if you need genome-wide results without experimental follow-up for most findings.

Add the scores. A total of 5 to 6 points indicates event-level analysis is the appropriate starting point. A total of 7 to 8 points suggests isoform-level analysis is feasible and may provide additional insight. A total of 9 to 10 points indicates a hybrid approach is warranted, using isoform-level analysis for discovery and event-level analysis for focused confirmation of key findings.

Implementing the Hybrid Approach

The hybrid approach deserves specific attention because it is increasingly common and addresses the limitations of each method individually. The strategy is to use long-read sequencing or isoform-level assembly on a subset of samples to establish the transcript structures present in your system, then use short-read event-level analysis across all samples for statistical comparison.

A study of Angiotensin II-induced senescence in rat aortic endothelial cells used this exact strategy, integrating PacBio Iso-seq with Illumina RNA-seq to analyze changes in alternative promoters, alternative splicing, and alternative polyadenylation [<a href="#ref-13">13</a>]. The long-read data generated 36,278 isoforms from 10,145 gene loci, with 65.81 percent of these isoforms being novel. The short-read data provided the statistical power to detect dynamic changes across conditions. This approach revealed that alternative splicing had more dynamic changes compared to alternative promoter and alternative polyadenylation usage upon Angiotensin II stimulation [<a href="#ref-13">13</a>].

For a newcomer, the hybrid approach can be implemented in stages. Start with event-level analysis on your short-read data to identify candidate events. Then, if resources permit, generate long-read data from a small number of representative samples to resolve the full isoform structures at those loci. Use the long-read information to refine your interpretation of the short-read results and to design validation experiments.

Records and Measurements for the Decision Framework

Document the scoring system and the rationale for your choice in your analysis notebook. Record the date of the decision, the person making it, and the specific criteria scores. This documentation matters because the choice between event-level and isoform-level analysis affects every subsequent result, and reviewers will ask why you chose one approach over the other.

Track the following measurements to evaluate whether your chosen approach is working. First, the number of splicing events or isoforms detected per sample. Second, the distribution of PSI values or isoform fractions across all detected features. Third, the number of significant differential splicing events or isoforms at your chosen thresholds. Fourth, the concordance between results from different tools if you run more than one.

If you chose event-level analysis, monitor whether the significant events cluster in a small number of genes or spread across many genes. If you chose isoform-level analysis, monitor whether the significant isoform changes are supported by the underlying read counts or driven by statistical estimation uncertainty.

Common Failure Patterns in the Decision Process

The most common failure is choosing isoform-level analysis with short-read data and an incomplete annotation, then spending weeks trying to interpret unreliable isoform assignments. This pattern produces results that cannot be validated experimentally because the predicted isoforms do not exist in the samples.

The second most common failure is choosing event-level analysis when the biological question requires understanding coordinated splicing changes. Event-level results present each event in isolation, and you may miss the fact that multiple events on the same transcript change together in a coordinated manner.

The third failure pattern is switching between approaches mid-analysis without documenting the change. This creates confusion about which results are trustworthy and makes the analysis difficult to reproduce. If you switch approaches, document the reason and treat the results from each approach as separate analyses.

The fourth failure pattern is ignoring the annotation quality assessment. Newcomers often assume that because an annotation file exists, it is complete and accurate. In practice, annotations vary widely in quality across organisms and even across gene families within the same organism. The NCBI Data Resources provide official descriptions of sequence resources and analysis services that can help you assess the quality of available annotations for your organism [<a href="#ref-8">8</a>].

When to Escalate to Expert Consultation

If your scoring system produces a total of 7 or higher but you have no experience with isoform-level analysis, consider consulting a bioinformatics specialist before proceeding. Isoform-level analysis has more failure modes than event-level analysis, and the errors are harder to detect because they are embedded in statistical estimation instead of in obvious alignment problems.

If you are working with a non-model organism that lacks a high-quality reference genome, escalate to expert consultation regardless of your score. The analysis strategies that work for well-annotated model organisms may not transfer directly, and you may need annotation-free approaches that require specialized expertise.

If your results from the two approaches conflict, meaning event-level analysis identifies significant changes that isoform-level analysis does not support or vice versa, escalate to expert consultation. This conflict often indicates a technical issue with one of the analyses, such as an alignment artifact or an annotation error, that requires experienced troubleshooting.

Integration with the Broader Analysis Workflow

The decision framework presented here operates at the start of the analysis, before you run any tools. It should be applied after you have completed quality control of your raw reads and before you choose your alignment and quantification tools. The decision affects the alignment parameters you use, the quantification tools you select, and the statistical models you apply.

The Bioconductor Project provides official package and workflow documentation that can help you identify maintained tools for either approach [<a href="#ref-9">9</a>]. The Galaxy Training Network offers accessible workflow training that covers both event-level and isoform-level analysis approaches in practical tutorials [<a href="#ref-6">6</a>]. The nf-core Documentation provides community pipeline standards that may include pre-built workflows for either analysis type [<a href="#ref-10">10</a>].

For a first splicing analysis, the safest path is to start with event-level analysis using a well-established tool such as rMATS, visualize the top events to confirm they are supported by the read data, and then decide whether the biological questions require the additional complexity of isoform-level analysis. This staged approach limits the risk of committing to a complex analysis before you understand the basic patterns in your data.

The decision framework also informs your validation strategy. Event-level findings can be validated with RT-PCR across the specific splice junction. Isoform-level findings require validation that distinguishes full-length isoforms, which may require long-read sequencing or isoform-specific PCR primers. A protocol for visual analysis of alternative splicing in RNA-seq data using integrated genome browser provides a structured approach to examining the read evidence for either type of finding [<a href="#ref-5">5</a>].

Practical Example of the Decision in Action

Consider a researcher studying salt stress responses in tomato roots. The biological question is whether salt stress induces alternative splicing changes and which genes are affected. The organism has a reference genome and annotation, but the annotation quality is moderate. The researcher has short-read RNA-seq data from control and salt-stressed samples with three biological replicates per condition.

Applying the scoring system, the biological question is exploratory, scoring 2. The annotation quality is moderate, scoring 1. The sequencing technology is short-read only, scoring 1. The replication is three per condition, scoring 2. The validation capacity is limited to RT-PCR for a small number of events, scoring 1. The total is 7, suggesting isoform-level analysis is feasible but with caution.

In practice, a study of salt stress in tomato roots used RNA-seq to identify 3,709 genes as differentially alternatively spliced, with exon skipping being the most prevalent event type [<a href="#ref-2">2</a>]. The study also identified more than 100 differentially expressed genes implicated in splicing and spliceosome assembly, which may regulate the salt-responsive splicing events [<a href="#ref-2">2</a>]. This scale of discovery was achievable with event-level analysis because the study focused on identifying the landscape of splicing changes instead of resolving full isoform structures.

The decision framework would recommend starting with event-level analysis for this scenario, then using isoform-level analysis selectively for genes of particular interest. This staged approach would have identified the same landscape of events while avoiding the complexity of full isoform reconstruction across all 3,709 differentially spliced genes.

Final Considerations for the Decision

The choice between event-level and isoform-level analysis is not permanent. Many research groups use both approaches in the same study, applying each where it is most appropriate. The key is to make the choice deliberately, document the rationale, and understand the limitations of each approach for your specific data and question.

The EMBL-EBI Training provides bioinformatics learning pathways that include practical education on splicing analysis approaches and their appropriate applications [<a href="#ref-11">11</a>]. The Carpentries Lessons provide foundational computing skills that will help you implement either approach with fewer errors [<a href="#ref-7">7</a>]. Investing time in understanding the decision framework before running tools will save more time than any computational optimization.

Remember that the goal of splicing analysis is not to produce the largest table of significant events but to answer a biological question with evidence that can withstand scrutiny. The decision framework presented here is designed to align your analysis approach with your biological question, your data characteristics, and your validation capacity. Applying it consistently will produce results that are interpretable, defensible, and useful for downstream experiments.

Frequently Asked Questions

What is the difference between gene-level differential expression and differential splicing analysis?

Gene-level differential expression analysis sums all reads across a gene to measure total expression. Differential splicing analysis measures the relative proportions of transcript isoforms. A gene can show no change in total expression while undergoing a dramatic shift in isoform usage. Conversely, a gene can change in total expression while maintaining the same isoform proportions. Both analyses are complementary and are often performed together on the same dataset.

How much sequencing depth do I need for alternative splicing analysis?

The required depth depends on the expression levels of the genes you care about and the magnitude of splicing changes you want to detect. Highly expressed genes can be analyzed at moderate depth, while lowly expressed genes require much deeper sequencing. A common approach is to sequence at least 30 to 50 million paired-end reads per sample for standard splicing analysis, with more depth needed for detecting rare isoforms or subtle changes.

What is Percent Spliced In and how do I interpret it?

Percent Spliced In, or PSI, is the percentage of transcripts that include a particular exon or splicing feature. A PSI of 0.9 means 90 percent of transcripts include the exon. Differential splicing analysis compares PSI values between conditions. A change from 0.9 to 0.5 represents a large shift in isoform usage, while a change from 0.95 to 0.90 is smaller but may still be biologically meaningful.

Should I use short-read or long-read sequencing for splicing analysis?

Short-read sequencing is more cost-effective and has more mature analysis tools. It is the standard choice for most splicing studies. Long-read sequencing can resolve full transcript structures and discover novel isoforms that short reads cannot detect [<a href="#ref-3">3</a>]. A hybrid approach that uses long reads for isoform discovery and short reads for quantification across many samples is increasingly common.

What are the main types of alternative splicing events?

The main event types are exon skipping, intron retention, alternative 5' splice site selection, alternative 3' splice site selection, and mutually exclusive exons. The dominant event type varies by species and condition. Exon skipping was most prevalent in salt-stressed tomato roots [<a href="#ref-2">2</a>], while intron retention dominated in bicarbonate-stressed soybean [<a href="#ref-3">3</a>].

How do I validate a differential splicing result?

Visual inspection of the read data is the first validation step. Sashimi plots and genome browser views show the actual reads supporting the splicing event [<a href="#ref-5">5</a>]. RT-PCR across the affected junction can confirm the splicing change experimentally. Running a second computational tool with a different approach can confirm that the result is not tool-specific.

What causes false positive splicing events?

False positives can arise from alignment errors, incomplete annotations, low read depth, batch effects, and statistical artifacts. Multi-mapping reads can be assigned to the wrong location. Incomplete annotations can cause novel junctions to be misclassified. Low read depth can make PSI estimates unreliable. Batch effects can create technical differences that are misinterpreted as biological splicing changes.

Can I analyze splicing from publicly available RNA-seq data?

Yes, many public RNA-seq datasets are available through databases such as NCBI [<a href="#ref-8">8</a>]. When using public data, check the sequencing platform, read length, strandedness, and whether biological replicates are available. The EMBL-EBI Training provides resources for learning how to access and analyze public data resources [<a href="#ref-11">11</a>].

Related Bioinformatics Guides

• Alternative Splicing Analysis from RNA-Seq Data
• Lipidomic Analysis: A Beginner's Guide to Workflows and Data Interpretation
• RNA-Seq vs DNA-Seq: Key Differences and Applications
• RNA-Seq Alignment Tools: STAR, HISAT2, and Beyond
• RNA-Seq Data Analysis in Galaxy: A User-Friendly Platform

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.